About InSilico Medicine

InSilico Medicine was founded in early 2014 and has since developed GeroScope platform for geroprotectors discovery and utilized the OncoFinder platform under exclusive license from Pathway Pharmaceuticals (Hong Kong) for drug discovery and drug repurposing in oncology.. It is a company dedicated to finding novel solutions towards aging and age-related diseases using advances in genomics and big data analysis. Through internal expertise and extensive collaborations with brilliant scientists, institutions, and highly credible pharmaceutical companies, InSilico Medicine seeks to revolutionize personalized science and drug discovery. More can be read about InSilico Medicine, Inc. at http://www.insilicomedicine.com.